Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors
Clinical trial NCT01188499 · COMPLETED
Trial details
- NCT number
- NCT01188499
- Sponsor
- TetraLogic Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.